Investigational new drugThyroid Analog
Compound 61660
Formula Pending
Molecular Mass
N/A
CAS Registry
AUTO-061660
Risk Class
LOW
Last Audit
May 30, 2108
Research Abstract
Thyroid Analog candidate engineered for metabolic regulation initiatives with automated dossier coverage.
Compound 61660 is a thyroid analog asset inside thyroid analog innovation track initiatives, optimized for metabolic regulation and cardiometabolic recovery.
The dossier currently sits in investigational new drug with a low risk rating, meaning it is cleared for baseline monitoring protocols.
Supply records cite CAS AUTO-061660 with updates logged 2108-05-30.
Acquisition Protocol
Authorized research personnel may request deployment of this compound for laboratory analysis.
Primary Vectors
Metabolic regulationCardiometabolic recovery
Nomenclature
CX-61660Thyroid Analog Program 61660
Reference Material
- [1] Anubis Compound Registry • CAS AUTO-061660
- [2] Operations Pulse • Thyroid Analog innovation track
- [3] Risk Governance Ledger • LOW clearance for COMPOUND-61660